# US 2004/0019196 A1 · Compositions and methods for using a solid support to purify RNA

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0019196 A1
- Document ID: US20040019196A1
- Status: Published application
- Kind: A1
- Application number: 10/418,194
- Filed: 2003-04-16
- Published: 2004-01-29
- Earliest claimed: 2001-10-12
- Assignees: Gentra Systems, Inc.
- Inventors: Robert Jackson Bair JR.; Ellen M. Heath; Heather Meehan; Kim Elayne Paulsen; John M. Wages JR.
- Web page: https://patentgrep.com/patent/US20040019196A1

## CPC

- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Reagents, methods and kits for the purification of RNA from biological materials are provided.

## Claims

### Claim 1

A formulation for isolating and purifying nucleic acids comprising:
a lithium salt at a concentration of at least about 1 M,
a detergent, and
a buffer.

### Claim 2 (depends on 1)

The formulation of claim 1, further comprising a chelating agent.

### Claim 3 (depends on 1)

The formulation of claim 1, further comprising a reducing agent.

### Claim 4 (depends on 1)

The formulation of claim 1, wherein the formulation lacks a chaotrope.

### Claim 5 (depends on 1)

The formulation of claim 1, wherein the lithium salt is lithium chloride.

### Claim 6 (depends on 1)

The formulation of claim 1, wherein the lithium salts is at a concentration of 4-10 M.

### Claim 7 (depends on 1)

The formulation of claim 1, wherein the formulation has pH of above about 7.

### Claim 8 (depends on 1)

The formulation of claim 1, wherein the solution has a pH between about 7 and about 9.

### Claim 9 (depends on 1)

The formulation of claim 1, wherein the solution has a pH below about 4.5.

### Claim 10 (depends on 1)

The formulation of claim 1, wherein the detergent is an anionic, cationic, zwitterionic or non-ionic detergent.

### Claim 11 (depends on 10)

The formulation of claim 10, wherein the detergent is a non-ionic detergent.

### Claim 12 (depends on 11)

The formulation of claim 11, wherein the detergent is a tween, triton, nonidet, igepal or tergitol.

### Claim 13 (depends on 1)

The formulation of claim 1, wherein the detergent is a mixture of triton-x and diethyl glycol monoethyl ether (DGME).

### Claim 14 (depends on 1)

The formulation of claim 1, wherein the detergent is a mixture of 5% v/v triton-x and 5% v/v DGME.

### Claim 15 (depends on 1)

The formulation of claim 1, wherein the detergent is present at a concentration of about 10% v/v of the final volume of the solution.

### Claim 16 (depends on 1)

The formulation of claim 1, wherein the buffer has a pKa of at least about 8.

### Claim 17 (depends on 1)

The formulation of claim 1, wherein the chelating agent is EDTA

### Claim 18 (depends on 1)

The formulation of claim 1, wherein the reducing agent is Tris (carboxyethyl) phosphine (TCEP).

### Claim 19 (depends on 1)

The formulation of claim 1, further comprising a tungstate.

### Claim 20

A method for purifying substantially pure and undegraded RNA from biological material comprising RNA, comprising the steps of:
(a) mixing the biological material with an RNA Lysing/Binding Solution buffered at a pH of greater than about 7, the RNA Lysing/Binding Solution comprising an RNA-complexing salt;
(b) contacting the mixture to a solid support such that nucleic acids comprising substantially undegraded RNA in the mixture preferentially bind to the solid support;
(c) washing the solid support with a series of RNA wash solutions to remove biological materials other than bound nucleic acids comprising substantially undegraded RNA, wherein the series of wash solutions comprises a first wash comprising alcohol and an RNA-complexing salt at a concentration of at least 1M and a second wash comprising an alcohol, buffer and an optional chelator; and
(d) preferentially eluting the bound substantially undegraded RNA from the solid support with an RNA Elution Solution in order to obtain substantially pure and undegraded RNA.

### Claim 21 (depends on 20)

The method of claim 20, wherein the RNA Lysing/Binding Solution is free of a strong chaotropic substance.

### Claim 22 (depends on 20)

The method of claim 20, wherein the RNA-complexing salt of the Lysing/Binding Solution is present at a concentration greater than about 4 M.

### Claim 23 (depends on 20)

The method of claims 20, wherein the RNA-complexing salt is an alkali metal salt.

### Claim 24 (depends on 23)

The method of claim 23, wherein the alkali-metal salt is present at a concentration of between 4-10 M.

### Claim 25 (depends on 20)

The method of claim 20, wherein the biological material is crude sample or apartially purified mixture of nucleic acids.

### Claim 26 (depends on 20)

The method of claim 20, wherein the biological material is a sample of eukaryotic cells, prokaryotic cells, microbial cells, bacterial cells, plant cells, mycoplasma, protozoa, bacteria, fungi, virus, yeast, or rickettsia, or homogenates thereof.

### Claim 27 (depends on 20)

The method of claim 20, wherein the biological material is whole blood, bone marrow, blood spot, blood serum, blood plasma, buffy coat preparation, saliva, cerebrospinal fluid, or solid animal tissue.

### Claim 28 (depends on 20)

The method of claim 20, wherein the biological material is feces, urine, tears, or sweat.

### Claim 29 (depends on 20)

The method of claim 20, wherein the biological material is an environmental sample taken from air, water, sediment or soil.

### Claim 30 (depends on 20)

The method of claim 20, wherein the solid support comprises components of silica, cellulose, cellulose acetate, nitrocellulose, nylon, polyester, polyethersulfone, polyolefin, or polyvinylidene fluoride, or combinations thereof.

### Claim 31 (depends on 20)

The method of claim 20, wherein the solid support is contained in a vessel, wherein the vessel is a centrifuge tube, spin tube, syringes, cartridge, chamber, multiple-well plate, or test tube, or combinations thereof.

### Claim 32 (depends on 20)

The method of claim 20, wherein the strong chaotropic substance is guanidinium salt, urea, ammonium, cesium, rubidium, potassium, or iodide salt.

### Claim 33 (depends on 20)

The method of claim 20, wherein the substantially pure and undegraded RNA is total RNA, messenger RNA, transfer RNA, ribosomal RNA or viral RNA, or combinations thereof.

### Claim 34 (depends on 20)

The method of claim 20, wherein the RNA-complexing salt of the Lysing/Binding and Wash Solutions is an alkali-metal salt.

### Claim 35 (depends on 34)

The method of claim 34, wherein the alkali-metal salt is a lithium salt.

### Claim 36 (depends on 34)

The method of claim 34, wherein the alkali-metal salt is lithium chloride or lithium bromide.

### Claim 37 (depends on 34)

The method of claim 34, wherein the alkali-metal salt is lithium chloride.

### Claim 38 (depends on 20)

The method of claim 20, wherein the chelating agent is EDTA or CDTA.

### Claim 39

A method for purifyting substantially pure and undegraded RNA from biological material comprising RNA, comprising the steps of:
(a) mixing the biological material with an RNA Lysing/Binding Solution, the RNA Lysing/Binding Solution comprising an amphiphillic reagent, and an RNA-complexing salt;
(b) lysing the biological material with the RNA Lysing/Binding Solution to form a lysate comprising nucleic acids comprising substantially undegraded RNA and non-nucleic acid biological matter;
(c) contacting the lysate to an immobilized solid support such that the nucleic acids comprising substantially undegraded RNA in the lysate preferentially bind to the solid support;
(d) washing the solid support with a series of RNA wash solutions to remove biological materials other than bound nucleic acids comprising substantially undegraded RNA, wherein the series of wash solutions comprises a first wash containing alcohol and an RNA-complexing salt at a concentration of at least 1M and a second wash containing an alcohol, buffer and an optional chelator; and
(e) preferentially eluting the bound substantially undegraded RNA from the solid support with an RNA Elution Solution in order to obtain substantially pure and undegraded RNA.

### Claim 40 (depends on 39)

The method of claim 39, wherein the RNA Lysing/Binding Solution is free of a strong chaotropic substance.

### Claim 41 (depends on 39)

The method of claim 39, wherein the RNA Lysing/Binding Solution is buffered at a pH of greater than about 7.

### Claim 42 (depends on 39)

The method of claim 39, wherein the biological material is a crude sample or partially purified mixture of nucleic acids.

### Claim 43 (depends on 39)

The method of claim 39, wherein the biological material comprises a sample of eukaryotic cells, prokaryotic cells, microbial cells, bacterial cells, plant cells, mycoplasma, protozoa, bacteria, fungi, viruses, yeasts, or rickettsia or homogenates thereof.

### Claim 44 (depends on 39)

The method of claim 39, wherein the biological material is whole blood, bone marrow, blood spots, blood serum, blood plasma, buffy coat preparations, saliva, cerebrospinal fluid, or solid animal tissues.

### Claim 45 (depends on 39)

The method of claim 39, wherein the biological material is feces, urine, tears, or sweat.

### Claim 46 (depends on 39)

The method of claim 39, wherein the biological material is an environmental sample taken from air, water, sediment or soil.

### Claim 47 (depends on 39)

The method of claim 39, wherein the non-silica solid support comprises components of silica, cellulose, cellulose acetate, nitrocellulose, nylon, polyester, polyethersulfone, polyolefin, polyvinylidene fluoride, or combinations thereof.

### Claim 48 (depends on 39)

The method of claim 39, wherein the solid support is contained in a vessel, wherein the vessel is a centrifuge tube, spin tube, syringe, cartridge, chamber, multiple-well plate, test tube, or combination thereof.

### Claim 49 (depends on 39)

The method of claim 39, wherein the strong chaotropic substance is a guanidinium salt and urea, ammonium, cesium, rubidium, potassium, or iodide salts.

### Claim 50 (depends on 39)

The method of claim 39, wherein the substantially pure and undegraded RNA is total RNA, messenger RNA, transfer RNA, ribosomal RNA or viral RNA, or a combination thereof.

### Claim 51 (depends on 39)

The method of claim 39, wherein the RNA-complexing salt is an alkali-metal salt.

### Claim 52 (depends on 51)

The method of claim 51, wherein the alkali-metal salt is a lithium salt.

### Claim 53 (depends on 51)

The method of claim 51, wherein the alkali-metal salt is a lithium chloride or lithium bromide salt.

### Claim 54 (depends on 51)

The method of claim 51, wherein the alkali-metal salt is lithium chloride.

### Claim 55 (depends on 51)

The method of claim 51, wherein the alkali-metal salt is present at a concentration greater than about 4 M.

### Claim 56 (depends on 51)

The method of claim 51, wherein the alkali-metal salt is present at a concentration of between 4-10 M.

### Claim 57 (depends on 39)

The method of claim 39, wherein the amphiphillic reagent is a detergent.

### Claim 58 (depends on 57)

The method of claim 57, wherein the detergent is a non-ionic detergent

### Claim 59 (depends on 58)

The method of claim 58, wherein the nonioinic detergent is a tween, triton, nonidet, igepal or tergitol.

### Claim 60 (depends on 39)

The method of claim 39, wherein the RNA Binding Solution optionally comprises a chelating agent.

### Claim 61 (depends on 60)

The method of claim 60, wherein the chelating agent is EDTA or CDTA.
